Alan Mitchell
Impact in
- Hematology top 2%
- Multiple Myeloma Research and Treatments
- Oncology top 10%
- Peptidase Inhibition and Analysis
- Lung Cancer Research Studies
Papers in
- Hematology 13
- Multiple Myeloma Research and Treatments 13
- Oncology 10
- Peptidase Inhibition and Analysis 5
- Cancer Treatment and Pharmacology 3
- Co-authors
- John Crowley (11 shared papers)Bart Barlogie (13 shared papers)Frits van Rhee (11 shared papers)Ramón Rami–Porta (2 shared papers)Gareth J. Morgan (6 shared papers)Wilfried Eberhardt (1 shared paper)Young Tae Kim (1 shared paper)Andrew T. Turrisi (1 shared paper)
- Journals
- Blood (12 papers)Journal of Thoracic Oncology (3 papers)Clinical Cancer Research (1 paper)Journal of Clinical Oncology (1 paper)Clinical Trials (1 paper)
- Partner nations
- United StatesSpainCanada
In The Last Decade
Alan Mitchell
19 papers receiving 848 citations
Peers
Comparison fields: 5 of 67
- Hematology 389
- Oncology 356
- Microbiology 9
- Pulmonary and Respiratory Medicine 362
- Radiology, Nuclear Medicine and Imaging 166
Countries citing papers authored by Alan Mitchell
This map shows the geographic impact of Alan Mitchell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Mitchell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Mitchell more than expected).
Fields of papers citing papers by Alan Mitchell
This network shows the impact of papers produced by Alan Mitchell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Mitchell. The network helps show where Alan Mitchell may publish in the future.
Co-authors
The 25 scholars most cited alongside Alan Mitchell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 260 | |
| 2 | 2014 | 169 | |
| 3 | 2013 | 145 | |
| 4 | 2016 | 92 | |
| 5 | 2016 | 53 | |
| 6 | 2013 | 45 | |
| 7 | 2016 | 37 | |
| 8 | 2018 | 19 | |
| 9 | 2013 | 13 | |
| 10 | 2014 | 6 | |
| 11 | 2014 | 5 | |
| 12 | 2014 | 3 | |
| 13 | 2013 | 1 | |
| 14 | 2015 | 1 | |
| 15 | 2015 | 1 | |
| 16 | 2010 | 1 | |
| 17 | 2010 | 1 | |
| 18 | 2012 | 1 | |
| 19 | 2011 | 1 |
About Alan Mitchell
Alan Mitchell is a scholar working on Hematology, Oncology, Molecular Biology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging, having authored 19 papers that have together received 854 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (13 papers), Protein Degradation and Inhibitors (7 papers), Peptidase Inhibition and Analysis (5 papers), Cancer Treatment and Pharmacology (3 papers), Radiation Dose and Imaging (2 papers), Lung Cancer Diagnosis and Treatment (2 papers), Pleural and Pulmonary Diseases (2 papers) and Lung Cancer Treatments and Mutations (2 papers). The work is most often cited by research in Hematology (389 citations), Oncology (356 citations), Microbiology (9 citations), Pulmonary and Respiratory Medicine (362 citations) and Radiology, Nuclear Medicine and Imaging (166 citations). Alan Mitchell has collaborated with scholars based in United States, Spain and Canada. Frequent co-authors include John Crowley, Bart Barlogie, Frits van Rhee, Ramón Rami–Porta, Gareth J. Morgan, Wilfried Eberhardt, Young Tae Kim, Andrew T. Turrisi, Haruhiko Kondo and Peter Goldstraw. Their work appears in journals such as Blood, Journal of Thoracic Oncology, Clinical Cancer Research, Journal of Clinical Oncology and Clinical Trials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.